| Darren Layne Shirley, MD | |
|
5955 Zeamer Ave, 673d Mdg,, Jber, AK 99506 | |
| (907) 580-6746 | |
| Not Available |
| Full Name | Darren Layne Shirley |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 5955 Zeamer Ave, Jber, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992786289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | P1225 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Providence Kodiak Island Medical Ctr | Kodiak, AK | Hospital |
| Providence Seward Hospital | Seward, AK | Hospital |
| Providence Valdez Medical Center | Valdez, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Radiology Associates Inc | 0648182725 | 19 |
| Alaska Radiology Associates Inc | 0648182725 | 19 |
| Imaging Associates Llc | 4284641986 | 18 |
News Archive
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
Less restrictive dietary options, better detection, targeted avoidance measures, educational directives and potential new therapies are improving food allergy management and giving hope to the more than 12 million Americans affected according to experts at the thirteenth international food allergy conference held during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Schizophrenia is the most disabling disease impacting youth today. It impacts 1% of the total population and typically causes withdrawal from society, loss in IQ, disordered thought and speech, hallucinations and delusions.
› Verified 2 days ago
| Entity Name | Alaska Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803214 PECOS PAC ID: 0648182725 Enrollment ID: O20240201001787 |
News Archive
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
Less restrictive dietary options, better detection, targeted avoidance measures, educational directives and potential new therapies are improving food allergy management and giving hope to the more than 12 million Americans affected according to experts at the thirteenth international food allergy conference held during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Schizophrenia is the most disabling disease impacting youth today. It impacts 1% of the total population and typically causes withdrawal from society, loss in IQ, disordered thought and speech, hallucinations and delusions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darren Layne Shirley, MD 13737 Noel Rd Ste 1600, Dallas, TX 75240-1374 Ph: (303) 933-8270 | Darren Layne Shirley, MD 5955 Zeamer Ave, 673d Mdg,, Jber, AK 99506 Ph: (907) 580-6746 |
News Archive
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
Less restrictive dietary options, better detection, targeted avoidance measures, educational directives and potential new therapies are improving food allergy management and giving hope to the more than 12 million Americans affected according to experts at the thirteenth international food allergy conference held during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Schizophrenia is the most disabling disease impacting youth today. It impacts 1% of the total population and typically causes withdrawal from society, loss in IQ, disordered thought and speech, hallucinations and delusions.
› Verified 2 days ago
Eldon Snyder, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-6760 | |
Dennis Dean Walker, DO Radiology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Avenue, 673d Mdg, Jber, AK 99506 Phone: 907-580-6760 |